REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
13/07/2026
Voltar para busca
Dado oficial do USPTO
VAXXAS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
VAXXAS
ST13
US500000079287747Classe
5, 10, 40, 42, 44, 45
Pedido
79287747
Registro
6413534
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
13/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 40, 42, 44, 45
Data de depósito
20/04/2020
Data de registro
13/07/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/07/2021
Última transação
13/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Sydney, NSW, AU
Examinador
LEASER, ANDREW C
Unidade examinadora
M80
Localização atual
TMO LAW OFFICE 117
Titulares e representantes
Titulares
Vaxxas Pty Ltd
Vaxxas Pty Ltd
Representantes
Gregory M. Krakau Krakau Law, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 40Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalmedicinal and therapeutic preparations for human and veterinary use for the treatment of infectious diseaseallergies and oncology; vaccines; vaccine preparations; diagnostic preparations for medical or veterinary purposes; biological specimensblood and plasma for human medical diagnostics and analysis; transdermal patchesbandagespoultices and medical dressings impregnated with vaccines; patchesbandagespoultices and medical dressings impregnated with vaccines; transdermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations for treating infectious diseaseallergies and oncology contained in transdermal patches; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment of infectious diseaseallergies and oncology; transdermal patches for administering pharmaceuticals for use in the treatment of infectious diseaseallergies and oncology and vaccines; intradermal patches for use in the medical treatment of infectious diseaseallergies and oncology; intradermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations contained in intradermal patches for use in the medical treatment of infectious diseaseallergies and oncology; skin patches for the intradermal delivery of pharmaceuticals for use in the treatment of infectious diseaseallergies and oncology; intradermal patches for medical treatment for administering pharmaceuticals for use in the medical treatment of infectious diseaseallergies and oncology and vaccines; micro-projection array patches for medical purposes impregnated with vaccines; structural parts and fittings for the aforesaid goods
Classe 10
Surgical and medical apparatus and instrumentsvaccine and drug delivery microneedle array patches sold without medication; drug delivery devices and apparatushermetically sealed applicators containing patches for applying vaccine sold without medication; drug delivery devices sold emptyuncoated patches sold without medication; transdermal drug delivery devices and apparatustransdermal drug delivery patches sold without medication; intradermal drug delivery devices and apparatusintradermal drug delivery patches sold without medication; micro-projection drug delivery devices and apparatusdrug delivery patches sold without medication; structural parts and fittings for the aforesaid goods
Classe 40
Custom manufacturing services in the field of drug delivery patches; custom manufacture of medical devicespharmaceuticalsdiagnostic tests and testing kits; custom manufacture of micro-projection array patches; custom manufacture of drug delivery devices and apparatus; custom manufacture of transdermal drug delivery devices and apparatus; custom manufacture of intradermal drug delivery devices and apparatus; custom manufacture of micro-projection drug delivery devices and apparatus; advisoryconsultancy and information services in relation to all of the aforesaid
Classe 42
Researchdesign and development services in the field of medical apparatus and instruments; medical researchdesign and development services in the field of drug delivery devices; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; drug discovery; vaccine screeningsafety testing of vaccines; scientific and technological research services related to immunopharmaceuticals and vaccines; biological researchclinical research in the field of immunologyvaccinesmedical research; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical and biochemical analysis services; medical and scientific research; pharmaceutical research services; laboratory testing services in the field of vaccinespharmaceuticals; laboratory research in the fields of biotechnologymicrobiologymolecular biologynanotechnology analytical chemistrybiochemistrymedicinal chemistry and drug development; technology servicesdesign and development of computer hardware; scientific researchclinical researchdevelopmentadvisory and consultancy services in relation to antibody production; research and development services in the field of antibodies; antibody generation services being research and development services; diagnostic and research services and screening in the field of infectious diseaseallergies and oncology for medical research purposes; diagnostic testing services in the field of medical apparatus and instruments; medical research services; advisory services relating to diagnostic testing of products for quality control and safety purposes; research and development of products; advisoryconsultancy and information services in relation to all of the aforesaid
Classe 44
Medicalmedical clinichealthcare services relating to vaccines; medical and veterinary consultancy; medical testing for diagnostic or treatment purposes; advisoryconsultancy and information services in relation to all of the aforesaid
Classe 45
Legal services relating to the exploitation and licensing of intellectual property and technology; licensing of medical technology; legal services relating to the licensing of research and development of products; advisoryconsultancy and information services in relation to all of the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
10/10/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/08/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/03/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
25/03/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/03/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/11/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/11/2021
FIMP
FINAL DISPOSITION PROCESSED
09/11/2021
ES7R
TEAS SECTION 7 REQUEST RECEIVED
31/10/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/10/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
13/07/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/04/2021
PUBO
PUBLISHED FOR OPPOSITION
27/04/2021
GPNX
NOTIFICATION PROCESSED BY IB
24/04/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/04/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/03/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/03/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
17/03/2021
GNFR
FINAL REFUSAL E-MAILED
17/03/2021
CNFR
FINAL REFUSAL WRITTEN
17/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/09/2020
GNRT
NON-FINAL ACTION E-MAILED
10/09/2020
CNRT
NON-FINAL ACTION WRITTEN
10/09/2020
RFNT
REFUSAL PROCESSED BY IB
30/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/08/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/08/2020
RFRR
REFUSAL PROCESSED BY MPU
11/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/07/2020
CNRT
NON-FINAL ACTION WRITTEN
19/07/2020
DOCK
ASSIGNED TO EXAMINER
11/07/2020
MAFR
APPLICATION FILING RECEIPT MAILED
24/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/06/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/06/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VAXXAS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.